Xu QH - Search Results

1

[The predictive value of ALT, HBeAg and HBV DNA levels at baseline and the degree of HBV suppression at week 12 adefovir dipivoxil treatment to the efficacy of it at week 52 in patients with HBeAg-positive chronic hepatitis B].

Xie DY, Lin BL, Xu QH, Chen YM, Lu WL, Li JG, Gao ZL. Xie DY, et al. Among authors: xu qh. Zhonghua Gan Zang Bing Za Zhi. 2008 May;16(5):341-4. Zhonghua Gan Zang Bing Za Zhi. 2008. PMID: 18510844 Chinese.

2

Interferon add-on therapy increased clinical cure significantly for interferon-experienced chronic hepatitis B patients with low HBsAg.

Yang X, Zhang K, Xu Q, Shu X, Mo Z, Xie D, Gao Z, Deng H. Yang X, et al. Front Immunol. 2022 Sep 6;13:997608. doi: 10.3389/fimmu.2022.997608. eCollection 2022. Front Immunol. 2022. PMID: 36148219 Free PMC article.

3

[Therapy effect of lamivudine combination with alpha interferon on patients with chronic hepatitis B].

Deng H, Zhao ZX, Xu QH, Zhou YP, Chen YM, Yao JL. Deng H, et al. Among authors: xu qh. Zhonghua Gan Zang Bing Za Zhi. 2003 May;11(5):305-8. Zhonghua Gan Zang Bing Za Zhi. 2003. PMID: 12773249 Chinese.

4

[The change of HBV nucleotide sequence during Adefovir dipivoxil treatment].

Lu JX, Xie DY, Xu QH, Zhu MF, Chen W, Li L, Li G. Lu JX, et al. Among authors: xu qh. Zhonghua Gan Zang Bing Za Zhi. 2006 May;14(5):331-6. Zhonghua Gan Zang Bing Za Zhi. 2006. PMID: 16732905 Chinese.

5

[Specific T cell immune response in chronic hepatitis B patients treated with different doses of recombinant hepatitis B vaccine].

Xu QH, Zhang XH, Xie DY, Li JG, Chong YT, Yang L, Lu WL, Gao ZL. Xu QH, et al. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2007 Dec;21(4):334-6. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2007. PMID: 18322594 Clinical Trial. Chinese.

6

[Relationship between SNP rs10774671 on OAS-1 gene and spontaneous HBeAg seroconversion in chronic HBV infection].

Chen LB, Peng XM, Cao H, Zhang YF, Xu QH, Gao ZL. Chen LB, et al. Among authors: xu qh. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2009 Feb;23(1):35-7. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2009. PMID: 19799013 Chinese.

7

[Genetic variation of IL-28B is associated with treatment response of patients with chronic hepatitis C].

Xie JQ, Zhang XH, Li XH, Xie DY, Xu QH. Xie JQ, et al. Among authors: xu qh. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2012 Aug;26(4):298-300. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2012. PMID: 23189850 Chinese.

8

[Short-term efficacy of adefovir dipivoxil as an add-on therapy in the pegylated IFNalpha-2a treatment for HBeAg positive chronic hepatitis B patients].

Chen LB, Shu X, Jie YS, Yang XA, Zhang K, Li G, Xu QH. Chen LB, et al. Among authors: xu qh. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2010 Feb;24(1):39-41. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2010. PMID: 20848847 Clinical Trial. Chinese.

9

[Efficacy of the 96-week adefovir dipivoxil therapy in patients with chronic hepatitis B].

Xu Z, Chen LB, Cao H, Shu X, Xu QH, Li G, Xie QF. Xu Z, et al. Among authors: xu qh. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2010 Jun;24(3):224-6. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2010. PMID: 21186534 Clinical Trial. Chinese.

10

[A clinical study on the efficacy of HBeAg-positive chronic hepatitis B patients treated with adefovir dipivoxil for 4 years].

Liang JY, Yang XA, Zhang K, Chen LB, Shu X, Xu QH. Liang JY, et al. Among authors: xu qh. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2011 Oct;25(5):384-6. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2011. PMID: 22338232 Clinical Trial. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

439 results

Search Page

Filters